Barrett’s and reflux registry at the Kansas City VA
Part of Cancer, Digestive system clinical trials.
This study follows people with confirmed Barrett’s esophagus (with or without concerning cell changes) and people who have reflux symptoms, to better understand how these conditions progress. It may help by building a Barrett’s registry so doctors can learn which factors predict worsening over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You receive care at the Kansas City VA Hospital
- You have confirmed Barrett’s esophagus, with or without dysplasia (or you have reflux disease)
- If you are in the “controls” group, you may be referred for endoscopy due to other signs (like anemia or weight loss) but not due to reflux or related concerns
- Your health conditions (heart, lungs, kidneys, liver, or metabolism) must be stable enough for the study
- You should not be on blood thinners in a way that raises bleeding risk from biopsies
- You must be able to share your medical history
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study focuses on people with Barrett’s esophagus who are coming in for an endoscopy check or for treatment of early surface changes. The goal is to better understand these early warning areas and how to manage them safely.
This Phase 2 trial tests whether obeticholic acid (a medicine) can help stop Barrett’s esophagus from getting worse. You must already be taking acid-suppressing medicine and have non-cancer Barrett’s changes, and the study checks safety and whether the lining improves or stays stable.
This study looks at how Barrett's esophagus affects your quality of life and fear of cancer. It uses new tests to better predict who might develop esophageal cancer, so you can get the right care sooner.
This study aims to screen for Barrett's esophagus in people who are getting a routine colonoscopy but do not have chronic heartburn. It uses a simple, non-invasive cell collection device (EsoCheck) to see if you might have Barrett's esophagus, which can increase the risk of esophageal cancer.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
This study tests a less invasive way to check for Barrett's esophagus and esophageal cancer. Instead of a standard endoscopy, they may use a sponge-on-a-string or other simpler methods, which could be more comfortable and easier for patients.
Hear when a new GERD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.